Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Tumour location as a predictor of benign disease in the management of renal masses.

Mason RJ, Abdolell M, Rendon RA.

Can Urol Assoc J. 2010 Dec;4(6):414-7.

2.

Solitary solid renal mass: can we predict malignancy?

Violette P, Abourbih S, Szymanski KM, Tanguay S, Aprikian A, Matthews K, Brimo F, Kassouf W.

BJU Int. 2012 Dec;110(11 Pt B):E548-52. doi: 10.1111/j.1464-410X.2012.11245.x. Epub 2012 May 22.

3.

Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.

Akdogan B, Gudeloglu A, Inci K, Gunay LM, Koni A, Ozen H.

Clin Genitourin Cancer. 2012 Jun;10(2):121-5. doi: 10.1016/j.clgc.2012.01.005. Epub 2012 Mar 7.

PMID:
22401753
4.

Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.

Mason RJ, Abdolell M, Trottier G, Pringle C, Lawen JG, Bell DG, Jewett MA, Klotz L, Rendon RA.

Eur Urol. 2011 May;59(5):863-7. doi: 10.1016/j.eururo.2011.02.023. Epub 2011 Feb 22.

PMID:
21353376
5.

A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.

Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight CJ, Campbell SC.

J Urol. 2007 Aug;178(2):429-34. Epub 2007 Jun 11.

PMID:
17561141
6.

Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.

Jeon HG, Lee SR, Kim KH, Oh YT, Cho NH, Rha KH, Yang SC, Han WK.

Urology. 2010 Sep;76(3):574-9. doi: 10.1016/j.urology.2009.11.082. Epub 2010 Mar 29.

PMID:
20303148
7.

Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.

Verma SK, Mitchell DG, Yang R, Roth CG, O'Kane P, Verma M, Parker L.

Radiology. 2010 May;255(2):501-7. doi: 10.1148/radiol.09091109. Epub 2010 Feb 16.

PMID:
20160001
8.

Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate.

Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM, Tan HJ, Woods ME, Raynor MC, Wallen EM, Pruthi RS, Nielsen ME.

J Urol. 2015 Jan;193(1):30-5. doi: 10.1016/j.juro.2014.07.102. Epub 2014 Jul 27. Review.

PMID:
25072182
9.

A classification tree for the prediction of benign versus malignant disease in patients with small renal masses.

Rendon RA, Mason RJ, Kirkland S, Lawen JG, Abdolell M.

Can J Urol. 2014 Aug;21(4):7379-84.

PMID:
25171283
10.

Is surveillance of small renal masses safe in the elderly?

O'Malley RL, Godoy G, Phillips CK, Taneja SS.

BJU Int. 2010 Apr;105(8):1098-101. doi: 10.1111/j.1464-410X.2009.08912.x. Epub 2009 Oct 22.

11.

Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.

Kim EH, Tanagho YS, Bhayani SB, Saad NE, Benway BM, Figenshau RS.

BJU Int. 2013 May;111(6):872-9. doi: 10.1111/j.1464-410X.2012.11432.x. Epub 2012 Nov 13.

12.

Assessing the anatomical characteristics of renal masses has a limited effect on the prediction of pathological outcomes in solid, enhancing, small renal masses: results using the PADUA classification system.

Shin TY, Kim J, Koo KC, Lim SK, Kim DW, Kang MW, Rha KH, Choi YD, Ham WS.

BJU Int. 2014 May;113(5):754-61. doi: 10.1111/bju.12446. Epub 2013 Nov 27.

13.

Predictors of locally advanced and metastatic disease in patients with small renal masses.

Kates M, Korets R, Sadeghi N, Pierorazio PM, McKiernan JM.

BJU Int. 2012 May;109(10):1463-7. doi: 10.1111/j.1464-410X.2011.10553.x. Epub 2011 Sep 20.

14.

Low incidence of benign lesions in resected suspicious renal masses greater than 2 cm: Single-center experience from Japan.

Soga N, Nishikawa K, Takaki H, Yamada Y, Arima K, Hayashi N, Sugimura Y.

Int J Urol. 2012 Aug;19(8):729-34. doi: 10.1111/j.1442-2042.2012.03030.x. Epub 2012 Apr 19.

15.

Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.

Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS.

BJU Int. 2012 Oct;110(7):956-60. doi: 10.1111/j.1464-410X.2012.10937.x. Epub 2012 Feb 2.

16.

Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.

Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, Ishikawa Y, Kumagai J, Kihara K, Fukui I.

Urology. 2008 Sep;72(3):598-602. doi: 10.1016/j.urology.2008.04.054. Epub 2008 Jul 23.

PMID:
18649929
17.

Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.

Rosenkrantz AB, Wehrli NE, Melamed J, Taneja SS, Shaikh MB.

Eur J Radiol. 2014 Aug;83(8):1311-6. doi: 10.1016/j.ejrad.2014.05.016. Epub 2014 May 17.

PMID:
24882784
18.

Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.

Beemster PW, Barwari K, Mamoulakis C, Wijkstra H, de la Rosette JJ, Laguna MP.

BJU Int. 2011 Aug;108(4):577-82. doi: 10.1111/j.1464-410X.2010.09807.x. Epub 2010 Nov 2.

19.

Renal tumour anatomical characteristics and functional outcome after partial nephrectomy.

Nisen H, Heimonen P, Kenttä L, Visapää H, Nisen J, Taari K.

Scand J Urol. 2015 Jun;49(3):193-9. doi: 10.3109/21681805.2014.978819. Epub 2014 Nov 11.

PMID:
25385687
20.

Under-grading of <4 cm renal masses on renal biopsy.

Harris CR, Whitson JM, Meng MV.

BJU Int. 2012 Sep;110(6):794-7. doi: 10.1111/j.1464-410X.2012.10944.x. Epub 2012 Mar 9.

Supplemental Content

Support Center